Dupilumab Faces Trial in Chronic Hives

• by Kathryn Wighton

• March 12, 2026

Cupping vs UVB: Comparable Psoriasis Outcomes?

Randomized study found no statistically significant differences in disease improvement between treatments over 8 weeks.

• by Meg Barbor

• April 9, 2026

• 2 min

Summary of Research: Apremilast Improves Skin Outcomes in Pediatric Plaque Psoriasis of Shorter Disease Duration: 52-Week Results from the SPROUT Phase 3 Trial

• by Richard G. Langley, Lisa Arkin, Loretta Fiorillo, Lawrence F. Eichenfield, Mark Lebwohl, Bruce Strober, Michael Sticherling, Lisa Swanson, Georgios Kokolakis, Siddharth Chaudhari, Cynthia Deignan, Zuoshun Zhang, Amy S. Paller

• May 14, 2026

Clinical and dermoscopic analysis of 32 cases of acquired facial hyperpigmented macules

• by Xiaoyi Chen, Yao Wu, Jing Xiao, Liansheng Zhong

• June 16, 2026